Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis

被引:13
作者
Hortal, L [1 ]
Fernàndez, A [1 ]
Vega, N [1 ]
Rodríguez, JC [1 ]
Losada, A [1 ]
Lorenzo, M [1 ]
Plaza, C [1 ]
Palop, L [1 ]
机构
[1] Hosp NS Pino, Serv Nefrol, Anal Clin S, Las Palmas Gran Canaria 35005, Canary Islands, Spain
关键词
D O I
10.1016/S0041-1345(98)00562-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2127 / 2128
页数:2
相关论文
共 3 条
[1]  
GASTON RS, 1994, AM J KIDNEY DIS, V24, P1
[2]   Losartan, an angiotensin-II receptor antagonist reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis [J].
Klaassen, RJL ;
VanGelder, T ;
RischenVos, J ;
Deinum, J ;
ManintVeld, AJ ;
Weimar, W .
TRANSPLANTATION, 1997, 64 (05) :780-782
[3]   Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients [J].
Kupin, W ;
Venkat, KK ;
Goggins, M ;
Abouljoud, M ;
Escobar, F ;
Mozes, M .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :207-208